Santé Ventures LLC raised $250 million for Sante Health Ventures III LP at final close.
The fund, which surpassed its target by 25%, obtained commitments from more than 30 limited partners, including the Pennsylvania Public School Employees' Retirement System. Other sponsors include sovereign wealth funds, Europe- and Asia-based investors, and several new healthcare delivery systems. The vehicle will build a portfolio of up to 25 investments.
It has committed approximately 6.5% of capital to several investments, including Cryosa Inc., which provides treatment for sleep apnea; DyaMX Inc., which offers treatment for Type II diabetes; and Geneos Therapeutics Inc., a neoantigen-based personalized cancer therapy provider.
Santé is a Texas-based venture capital firm focused on early-stage companies in the healthcare and life sciences markets.